Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kedar Kirtane

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|December 20, 2018
Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)Kedar Kirtane, Cristina P Rodriguez
Blood|July 21, 2017
Racial and ethnic disparities in hematologic malignanciesKedar Kirtane, Stephanie J Lee
Current Treatment Options in Oncology|February 13, 2020
Emerging Therapies for Radioactive Iodine Refractory Thyroid CancerKedar Kirtane, Mara Y Roth
Best Practice & Research. Clinical Haematology|October 9, 2021
TCR gene-engineered cell therapy for solid tumorsElaine Tan, Neel Gakhar, Kedar Kirtane
JCO Precision Oncology|December 10, 2025
Durable Complete Response of a Delta-Like Ligand 3 Expressing Head and Neck Neuroendocrine Carcinoma to TarlatamabKedar Kirtane, Sonam Puri, Christine H Chung
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2026
Emerging Treatments and Novel Modalities in Head and Neck CancersKedar Kirtane, Harsh Dhar, Anil D'Cruz, et al.
Cancers|January 22, 2021
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell CarcinomaJameel Muzaffar, Shahla Bari, Kedar Kirtane, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 6, 2019
Leaving footprints, not scars: a qualitative pilot study of Hispanic mothers' willingness to communicate with dependent children about an advanced cancer diagnosisElizabeth T Loggers, Kedar Kirtane, Rebecca Palacios, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges aheadKedar Kirtane, Hany Elmariah, Christine H Chung, et al.
Journal of Psychosocial Oncology|January 30, 2025
The patient and caregiver experience of CAR T-cell therapy: A qualitative analysisMaija Reblin, Irene Liang, Djin L Tay, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|December 20, 2018
Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)Kedar Kirtane, Cristina P Rodriguez
Blood|July 21, 2017
Racial and ethnic disparities in hematologic malignanciesKedar Kirtane, Stephanie J Lee
Current Treatment Options in Oncology|February 13, 2020
Emerging Therapies for Radioactive Iodine Refractory Thyroid CancerKedar Kirtane, Mara Y Roth
Best Practice & Research. Clinical Haematology|October 9, 2021
TCR gene-engineered cell therapy for solid tumorsElaine Tan, Neel Gakhar, Kedar Kirtane
JCO Precision Oncology|December 10, 2025
Durable Complete Response of a Delta-Like Ligand 3 Expressing Head and Neck Neuroendocrine Carcinoma to TarlatamabKedar Kirtane, Sonam Puri, Christine H Chung
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2026
Emerging Treatments and Novel Modalities in Head and Neck CancersKedar Kirtane, Harsh Dhar, Anil D'Cruz, et al.
Cancers|January 22, 2021
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell CarcinomaJameel Muzaffar, Shahla Bari, Kedar Kirtane, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 6, 2019
Leaving footprints, not scars: a qualitative pilot study of Hispanic mothers' willingness to communicate with dependent children about an advanced cancer diagnosisElizabeth T Loggers, Kedar Kirtane, Rebecca Palacios, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges aheadKedar Kirtane, Hany Elmariah, Christine H Chung, et al.
Journal of Psychosocial Oncology|January 30, 2025
The patient and caregiver experience of CAR T-cell therapy: A qualitative analysisMaija Reblin, Irene Liang, Djin L Tay, et al.
Pageof 6